Andaleb Kholmukhamedov/LinkedIn
Oct 5, 2025, 07:47
Andaleb Kholmukhamedov: A Critical Field Balancing Life-Saving Clot Prevention With Bleeding Risk
Andaleb Kholmukhamedov, Head of Hemostasis Assay Development, Werfen North America, shared a post on LinkedIn:
“Latest publication in the MDPI Journal of Clinical Medicine’s Special Issue on Advances in Thrombosis and Haemostasis!
Our paper provides a comprehensive review of the current and future landscape of Anticoagulation Therapy – a critical field balancing life-saving clot prevention with bleeding risk.”
Title: Anticoagulation Management: Current Landscape and Future Trends
Authors: Andaleb Kholmukhamedov, David Subbotin, Anna Gorin, Ruslan Ilyassov
Read full article here.
Stay updated with Hemostasis Today.
-
Feb 28, 2026, 17:03Investing in Education, Prevention, and Lifesaving Research for a Healthier Tomorrow – AHA
-
Feb 28, 2026, 17:00Pamela Gavin: 1 in 10 Americans Live With A Rare Disease – That Is Not Rare, That Is Public Health
-
Feb 28, 2026, 16:59Thomas Rocco Jr: Exploring Agentic AI in Cardiovascular Medicine
-
Feb 28, 2026, 16:50Rob Maloney: Normalcy Is Not A Small Thing In Rare Disease
-
Feb 28, 2026, 16:49Céline Chapelle: Evaluating 6-Month Risks of Recurrent VTE and Major Bleeding With Tinzaparin
-
Feb 28, 2026, 16:46Nicolas Hulscher: Nattokinase Dissolves 84% of Amyloid Microclots In Vitro
-
Feb 28, 2026, 16:46Alfonso Tafur: Preventing Post-Hospitalization Blood Clots Using Precision Tools and Systems
-
Feb 28, 2026, 16:39Anel Karisik: Do Antidepressants Influence Swallowing Recovery After Acute Ischemic Stroke?
-
Feb 28, 2026, 16:38Akinchan Bhardwaj: Targeting SBK2 for Selective Inflammasome Resolution in Atherosclerosis